CARA logo

Cara Therapeutics (CARA) Total Liabilities

Annual Total Liabilities

$68.76 M
+$45.30 M+193.12%

31 December 2023

CARA Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$50.62 M
-$10.28 M-16.87%

30 September 2024

CARA Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CARA Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+193.1%+70.5%
3 y3 years+210.3%+182.8%
5 y5 years+20.2%-2.5%

CARA Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+252.0%-26.4%+203.5%
5 y5 yearsat high+252.0%-26.4%+203.5%
alltimeall timeat high+2119.5%-26.4%+1534.0%

Cara Therapeutics Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$50.62 M(-16.9%)
June 2024
-
$60.90 M(+1.0%)
Mar 2024
-
$60.30 M(-12.3%)
Dec 2023
$68.76 M(+193.1%)
$68.76 M(+131.5%)
Sept 2023
-
$29.70 M(+16.7%)
June 2023
-
$25.46 M(+52.6%)
Mar 2023
-
$16.68 M(-28.9%)
Dec 2022
$23.46 M(+20.1%)
$23.46 M(-18.2%)
Sept 2022
-
$28.69 M(+29.5%)
June 2022
-
$22.15 M(+12.1%)
Mar 2022
-
$19.75 M(+1.1%)
Dec 2021
$19.53 M(-11.8%)
$19.53 M(+9.1%)
Sept 2021
-
$17.90 M(-0.5%)
June 2021
-
$17.99 M(-9.0%)
Mar 2021
-
$19.77 M(-10.8%)
Dec 2020
$22.16 M(-52.1%)
$22.16 M(+14.9%)
Sept 2020
-
$19.29 M(-30.3%)
June 2020
-
$27.68 M(-22.4%)
Mar 2020
-
$35.70 M(-22.8%)
Dec 2019
$46.25 M(-19.1%)
$46.25 M(-10.9%)
Sept 2019
-
$51.90 M(+3.6%)
June 2019
-
$50.10 M(-10.6%)
Mar 2019
-
$56.06 M(-2.0%)
DateAnnualQuarterly
Dec 2018
$57.19 M(+459.4%)
$57.19 M(-9.5%)
Sept 2018
-
$63.17 M(-5.5%)
June 2018
-
$66.82 M(+683.1%)
Mar 2018
-
$8.53 M(-16.5%)
Dec 2017
$10.22 M(-22.0%)
$10.22 M(+13.9%)
Sept 2017
-
$8.97 M(+2.5%)
June 2017
-
$8.75 M(-37.6%)
Mar 2017
-
$14.03 M(+7.1%)
Dec 2016
$13.10 M(+123.9%)
$13.10 M(+56.9%)
Sept 2016
-
$8.35 M(-11.7%)
June 2016
-
$9.46 M(+33.5%)
Mar 2016
-
$7.09 M(+21.1%)
Dec 2015
$5.85 M(+37.0%)
$5.85 M(+45.1%)
Sept 2015
-
$4.03 M(+1.6%)
June 2015
-
$3.97 M(-6.1%)
Mar 2015
-
$4.23 M(-1.0%)
Dec 2014
$4.27 M(-35.0%)
$4.27 M(-39.3%)
Sept 2014
-
$7.04 M(+6.2%)
June 2014
-
$6.63 M(-2.9%)
Mar 2014
-
$6.83 M(+3.9%)
Dec 2013
$6.57 M(+112.1%)
$6.57 M(-22.5%)
Sept 2013
-
$8.48 M(+173.6%)
Dec 2012
$3.10 M(-32.4%)
$3.10 M
Dec 2011
$4.58 M
-

FAQ

  • What is Cara Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Cara Therapeutics?
  • What is Cara Therapeutics annual total liabilities year-on-year change?
  • What is Cara Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Cara Therapeutics?
  • What is Cara Therapeutics quarterly total liabilities year-on-year change?

What is Cara Therapeutics annual total liabilities?

The current annual total liabilities of CARA is $68.76 M

What is the all time high annual total liabilities for Cara Therapeutics?

Cara Therapeutics all-time high annual total liabilities is $68.76 M

What is Cara Therapeutics annual total liabilities year-on-year change?

Over the past year, CARA annual total liabilities has changed by +$45.30 M (+193.12%)

What is Cara Therapeutics quarterly total liabilities?

The current quarterly total liabilities of CARA is $50.62 M

What is the all time high quarterly total liabilities for Cara Therapeutics?

Cara Therapeutics all-time high quarterly total liabilities is $68.76 M

What is Cara Therapeutics quarterly total liabilities year-on-year change?

Over the past year, CARA quarterly total liabilities has changed by +$20.93 M (+70.47%)